Hemostemix Inc. (TSXV:HEM)
0.1300
0.00 (0.00%)
Jun 26, 2025, 10:48 AM EDT
Hemostemix Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 0.97 | 0.71 | 0.16 | 0.14 | 0.22 | 0.26 | Upgrade
|
Cash & Short-Term Investments | 0.97 | 0.71 | 0.16 | 0.14 | 0.22 | 0.26 | Upgrade
|
Cash Growth | 2652.19% | 354.07% | 14.49% | -38.14% | -14.93% | 971.94% | Upgrade
|
Other Receivables | 0.07 | 0.23 | 0.03 | 0.14 | 0.34 | 2.06 | Upgrade
|
Receivables | 0.07 | 0.23 | 0.03 | 0.14 | 0.34 | 2.06 | Upgrade
|
Prepaid Expenses | 0.05 | 0.06 | 0.13 | 0.19 | - | - | Upgrade
|
Total Current Assets | 1.08 | 0.99 | 0.31 | 0.46 | 0.56 | 2.32 | Upgrade
|
Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Total Assets | 1.23 | 0.99 | 0.31 | 0.47 | 0.56 | 2.32 | Upgrade
|
Accounts Payable | 3 | 2.21 | 2.62 | 2.62 | 3.31 | 1.98 | Upgrade
|
Accrued Expenses | 0.52 | 0.57 | 0.25 | 0 | 0.01 | 0.03 | Upgrade
|
Short-Term Debt | - | - | - | - | - | 0.18 | Upgrade
|
Other Current Liabilities | - | - | - | - | 1.04 | 1.24 | Upgrade
|
Total Current Liabilities | 3.51 | 2.77 | 2.88 | 2.62 | 4.37 | 3.42 | Upgrade
|
Long-Term Debt | 4.69 | 4.94 | 4.32 | 4.13 | 1.48 | - | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.49 | 0.49 | 0.49 | 0.49 | - | - | Upgrade
|
Total Liabilities | 8.69 | 8.2 | 7.68 | 7.23 | 5.85 | 3.42 | Upgrade
|
Common Stock | 44.42 | 43.92 | 42.48 | 41.08 | 38.67 | 37.89 | Upgrade
|
Additional Paid-In Capital | 13.76 | 13.22 | 11.93 | 10.25 | 10.06 | 8.71 | Upgrade
|
Retained Earnings | -67.02 | -65.88 | -63.27 | -60.76 | -55.53 | -49.24 | Upgrade
|
Comprehensive Income & Other | 1.38 | 1.54 | 1.49 | 2.67 | 1.52 | 1.54 | Upgrade
|
Shareholders' Equity | -7.47 | -7.2 | -7.37 | -6.77 | -5.28 | -1.1 | Upgrade
|
Total Liabilities & Equity | 1.23 | 0.99 | 0.31 | 0.47 | 0.56 | 2.32 | Upgrade
|
Total Debt | 4.69 | 4.94 | 4.32 | 4.13 | 1.48 | 0.18 | Upgrade
|
Net Cash (Debt) | -3.73 | -4.23 | -4.17 | -3.99 | -1.26 | 0.08 | Upgrade
|
Net Cash Per Share | -0.04 | -0.04 | -0.05 | -0.06 | -0.02 | 0.00 | Upgrade
|
Filing Date Shares Outstanding | 145.31 | 145.31 | 87.12 | 75.74 | 68.2 | 56.25 | Upgrade
|
Total Common Shares Outstanding | 145.31 | 140.64 | 87.12 | 75.74 | 59.15 | 55.54 | Upgrade
|
Working Capital | -2.43 | -1.78 | -2.56 | -2.16 | -3.8 | -1.1 | Upgrade
|
Book Value Per Share | -0.05 | -0.05 | -0.08 | -0.09 | -0.09 | -0.02 | Upgrade
|
Tangible Book Value | -7.47 | -7.2 | -7.37 | -6.77 | -5.28 | -1.1 | Upgrade
|
Tangible Book Value Per Share | -0.05 | -0.05 | -0.08 | -0.09 | -0.09 | -0.02 | Upgrade
|
Machinery | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
Updated Nov 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.